United States of America

3 Vaccines Approved for Use in United States of America

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: nytimes.com
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: bbc.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: nytimes.com

42 in Clinical Trials in United States of America

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Protein Subunit

COVAXX

UB-612

7 trials in 2 countries
Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
VLP

Medicago

Covifenz

Approved in 1 country
6 trials in 6 countries
DNA

Inovio

INO-4800

9 trials in 9 countries
RNA

Arcturus Therapeutics Inc

ARCT-154

6 trials in 3 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
RNA

Pfizer/BioNTech

BNT162b2s01

3 trials in 2 countries
RNA

Pfizer/BioNTech

BNT162b1

5 trials in 3 countries
RNA

Moderna

mRNA-1273.617.2

2 trials in 1 country
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
RNA

Moderna

mRNA-1273.213

2 trials in 1 country
RNA

Moderna

mRNA-1273.211

4 trials in 1 country
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
14 trials in 2 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Protein Subunit

Kentucky Bioprocessing

KBP-201

2 trials in 1 country
RNA

Arcturus Therapeutics Inc

ARCT-165

2 trials in 2 countries
RNA

Arcturus Therapeutics Inc

LUNAR-COV19/ARCT-021

6 trials in 2 countries
RNA

Moderna

mRNA-1283

2 trials in 1 country
RNA

Moderna

mRNA-1283.211

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7 + B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.617.2)

Non Replicating Viral Vector

ImmunityBio Inc

hAd5-Covid-19

7 trials in 2 countries
Non Replicating Viral Vector

Mahidol University

NDV-HXP-S

7 trials in 3 countries
Non Replicating Viral Vector

Vaxart

VXA-CoV2-1.1-S

Replicating Viral Vector

Aivita Biomedical Inc

AV-COVID-19

4 trials in 2 countries
Replicating Viral Vector

City of Hope Medical Center

COH04S1

2 trials in 1 country
Protein Subunit

US Army Medical Research and Development Command

SpFN COVID-19 Vaccine

DNA

Providence Health & Services

CORVax12

RNA

GlaxoSmithKline

CoV2 SAM (LNP)

RNA

GlaxoSmithKline

CV2CoV

RNA

HDT Bio

HDT-301

RNA

Moderna

mRNA-1273.351

Non Replicating Viral Vector

CyanVac LLC

CVXGA1

Non Replicating Viral Vector

NIAID

ChAdV68-S

Non Replicating Viral Vector

NIAID

SAM-LNP-S

Non Replicating Viral Vector

Vaxart

VXA-CoV2-1

Replicating Viral Vector

Meissa Vaccines Inc

MV-014-212

RNA

Moderna

mRNA-1073

2 trials in 1 country

4 Vaccines with Trials in United States of America are No Longer Progressing

Non Replicating Viral Vector

Altimmune Inc

AdCOVID

Replicating Viral Vector

Merck Sharp & Dohme Corp

V590

Replicating Viral Vector

Merck Sharp & Dohme Corp

V591

2 trials in 3 countries
RNA

Sanofi Pasteur

MRT5500

2 trials in 1 country